{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:14:25Z","timestamp":1792433665871,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82374178"],"award-info":[{"award-number":["82374178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2022MH180"],"award-info":[{"award-number":["ZR2022MH180"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02572-6","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:12:52Z","timestamp":1738573972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The anti-cancer activity of Dioscin: an update and future perspective"],"prefix":"10.1007","volume":"42","author":[{"given":"MengYue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaNan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SongLin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiaoLan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoLin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShiJun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"1","key":"2572_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024 [J]. CA: A Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA: A Cancer J Clin"},{"issue":"10","key":"2572_CR2","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.13863\/j.issn1001-4454.2021.10.043","volume":"44","author":"J Zhu","year":"2021","unstructured":"Zhu J, Yang G, Yang Y, et al. Research progress on anti-tumor signaling pathways of bilobonins [J]. J Chinese Med Mater. 2021;44(10):2485\u201390. https:\/\/doi.org\/10.13863\/j.issn1001-4454.2021.10.043.","journal-title":"J Chinese Med Mater"},{"issue":"1","key":"2572_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1248\/cpb1953.4.35","volume":"4","author":"T Tsukamoto","year":"1956","unstructured":"Tsukamoto T, Kawasaki T, Yamauchi T. Saponins of Japanese Dioscoreaceae. V. On the structure of dioscin [J]. Pharma Bull. 1956;4(1):35\u201342. https:\/\/doi.org\/10.1248\/cpb1953.4.35.","journal-title":"Pharma Bull"},{"issue":"1","key":"2572_CR4","first-page":"36","volume":"40","author":"L Xu","year":"2015","unstructured":"Xu L, Wei Y, Peng J. Advances in study of dioscin-a natural product[J]. China J Chin Materia Med. 2015;40(1):36\u201341.","journal-title":"China J Chin Materia Med"},{"issue":"9","key":"2572_CR5","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1039\/d0np00057d","volume":"38","author":"CL Yao","year":"2021","unstructured":"Yao CL, Zhang JQ, Li JY, et al. Traditional Chinese medicine (TCM) as a source of new anticancer drugs [J]. Nat Prod Rep. 2021;38(9):1618\u201333. https:\/\/doi.org\/10.1039\/d0np00057d.","journal-title":"Nat Prod Rep"},{"issue":"2","key":"2572_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3969\/i.issn.1001-1978.2017.02.004","volume":"33","author":"S Wang","year":"2017","unstructured":"Wang S, Ling S, Zhang Q, et al. Advance on the pharmacological research of dioscin [J]. Chinese Pharma Bull. 2017;33(2):161\u20136. https:\/\/doi.org\/10.3969\/i.issn.1001-1978.2017.02.004.","journal-title":"Chinese Pharma Bull"},{"issue":"18","key":"2572_CR7","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.3969\/i.issn.1671-8348.2020.18.033","volume":"49","author":"S Wang","year":"2020","unstructured":"Wang S, Wu M, Huang Y. 2020 Research progress on anticancer mechanism of dioscin [J]. Chongqing Med J. 2020;49(18):3123\u20136. https:\/\/doi.org\/10.3969\/i.issn.1671-8348.2020.18.033.","journal-title":"Chongqing Med J"},{"key":"2572_CR8","unstructured":"Miao Changxin, Leng Jinhong. Research progress on pharmacological effects and mechanism of dioscin[J]. Chinese Archives of Traditional Chinese Medicine, 2024: 1\u201310. https:\/\/link.cnki.net\/urlid\/21.1546.R.20240228.1749.013"},{"issue":"6805","key":"2572_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35037710","volume":"407","author":"MO Hengartner","year":"2000","unstructured":"Hengartner MO. The biochemistry of apoptosis [J]. Nature. 2000;407(6805):770\u20136. https:\/\/doi.org\/10.1038\/35037710.","journal-title":"Nature"},{"issue":"6","key":"2572_CR10","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1074\/jbc.M112.401299","volume":"288","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Oh YJ, Han SH, et al. Cdk1 protein-mediated phosphorylation of receptor-associated protein 80 (RAP80) serine 677 modulates DNA damage-induced G2\/M checkpoint and cell survival[J]. J Biol Chem. 2013;288(6):3768\u201376. https:\/\/doi.org\/10.1074\/jbc.M112.401299.","journal-title":"J Biol Chem"},{"issue":"3","key":"2572_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.15430\/JCP.2021.26.3.183","volume":"26","author":"WO Chae","year":"2021","unstructured":"Chae WO, Kim GD. Dioscin Decreases breast cancer stem-like cell proliferation via cell cycle arrest by modulating p38 mitogen-activated protein kinase and AKT\/mTOR signaling pathways [J]. J Cancer Prev. 2021;26(3):183\u201394. https:\/\/doi.org\/10.15430\/JCP.2021.26.3.183.","journal-title":"J Cancer Prev"},{"key":"2572_CR12","doi-asserted-by":"publisher","first-page":"111941","DOI":"10.1016\/j.fct.2020.111941","volume":"148","author":"XL Li","year":"2021","unstructured":"Li XL, Ma RH, Ni ZJ, et al. Dioscin inhibits human endometrial carcinoma proliferation via G0\/G1 cell cycle arrest and mitochondrial-dependent signaling pathway [J]. Food Chem Toxicol Int J Publish British Ind Biol Res Assoc. 2021;148:111941.","journal-title":"Food Chem Toxicol Int J Publish British Ind Biol Res Assoc"},{"issue":"3","key":"2572_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41419-018-0363-x","volume":"9","author":"W Liu","year":"2018","unstructured":"Liu W, Zhao Z, Wang Y, et al. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt\/GSK3\/\u03b2-catenin signaling pathway [J]. Cell Death Dis. 2018;9(3):343. https:\/\/doi.org\/10.1038\/s41419-018-0363-x.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2572_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.16519\/j.cnki.1004-311x.2024.03.0053","volume":"34","author":"X Yang","year":"2024","unstructured":"Yang X, Xu W, Li H. Diosgenin regulates the Wnt\/\u03b2-catenin pathway and influences the metastasis activity of oral squamous cell [J]. Biotechnology. 2024;34(3):364\u20139. https:\/\/doi.org\/10.16519\/j.cnki.1004-311x.2024.03.0053.","journal-title":"Biotechnology"},{"issue":"8","key":"2572_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molmed.2023.05.006","volume":"29","author":"D Han","year":"2023","unstructured":"Han D, Wang L, Jiang S, et al. The ubiquitin-proteasome system in breast cancer [J]. Trends Mol Med. 2023;29(8):599\u2013621. https:\/\/doi.org\/10.1016\/j.molmed.2023.05.006.","journal-title":"Trends Mol Med"},{"issue":"6","key":"2572_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3971\/j.issn.1000-8578.2023.23.0326","volume":"50","author":"X Li","year":"2023","unstructured":"Li X, Wang J, Ke X, et al. Dioscin inhibits ubiquitin-proteasome system in cancer cells [J]. Cancer Res Prev Treat. 2023;50(6):567\u201372. https:\/\/doi.org\/10.3971\/j.issn.1000-8578.2023.23.0326.","journal-title":"Cancer Res Prev Treat"},{"issue":"8","key":"2572_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3969\/i.issn.1003-1634.2020.08.015","volume":"36","author":"Z Qing","year":"2020","unstructured":"Qing Z, Feng G, Ming Li. Research progress on antitumor mechanism of diosgenin and its inhibition of oral squamous cell carcinoma [J]. J Clin Stomatol. 2020;36(8):505\u20137. https:\/\/doi.org\/10.3969\/i.issn.1003-1634.2020.08.015.","journal-title":"J Clin Stomatol"},{"key":"2572_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OTT.S224062","volume":"13","author":"Z Wu","year":"2020","unstructured":"Wu Z, Han X, Tan G, et al. Dioscin Inhibited glycolysis and induced cell apoptosis in colorectal cancer via promoting c-myc ubiquitination and subsequent hexokinase-2 suppression [J]. Onco Targets Ther. 2020;13:31\u201344. https:\/\/doi.org\/10.2147\/OTT.S224062.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"2572_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.16519\/j.cnki.1004-311x.2023.05.0093","volume":"33","author":"R Fu","year":"2023","unstructured":"Fu R, Cao B, Wang T. Mechanisms of the effect of diosgenin on the cellular biological processes of lung cancer cells [J]. Biotechnology. 2023;33(5):616\u201320. https:\/\/doi.org\/10.16519\/j.cnki.1004-311x.2023.05.0093.","journal-title":"Biotechnology"},{"issue":"5","key":"2572_CR20","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/med.21675","volume":"40","author":"MD Asmamaw","year":"2020","unstructured":"Asmamaw MD, Liu Y, Zheng YC, et al. Skp2 in the ubiquitin-proteasome system: a comprehensive review [J]. Med Res Rev. 2020;40(5):1920\u201349. https:\/\/doi.org\/10.1002\/med.21675.","journal-title":"Med Res Rev"},{"key":"2572_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.031","volume":"51","author":"L Zhou","year":"2020","unstructured":"Zhou L, Yu X, Li M, et al. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth [J]. EBioMedicine. 2020;51: 102570. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.031.","journal-title":"EBioMedicine"},{"key":"2572_CR22","unstructured":"Xu D, Gao J. Relationship between long non-coding RNA and gastric cancer[J]. Medicine and Pharmacy of Yunnan, 2017, 38(4): 431\u2013433. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CJFQ&dbname=cjfdlast2017&filename=YNYY201704052"},{"issue":"1","key":"2572_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12906-016-1360-1","volume":"16","author":"T Ma","year":"2016","unstructured":"Ma T, Wang RP, Zou X. Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR[J]. BMC Complement Altern Med. 2016;16(1):383. https:\/\/doi.org\/10.1186\/s12906-016-1360-1.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"2572_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death [J]. Nat Rev Mol Cell Biol. 2008;9(1):47\u201359. https:\/\/doi.org\/10.1038\/nrm2308.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2572_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.fct.2018.07.016","volume":"120","author":"YS Zhang","year":"2018","unstructured":"Zhang YS, Ma YL, Thakur K, et al. Molecular mechanism and inhibitory targets of dioscin in HepG2 cells [J]. Food Chem Toxicol. 2018;120:143\u201354. https:\/\/doi.org\/10.1016\/j.fct.2018.07.016.","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"2572_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.13982\/j.mfst.1673-9078.2021.8.0623","volume":"37","author":"Y Liang","year":"2021","unstructured":"Liang Y, Huang Q, Chen L, et al. Inhibitory effects of dioscin on the proliferation of HepG2 cells [J]. Modern Food Sci Technol. 2021;37(8):62\u20136. https:\/\/doi.org\/10.13982\/j.mfst.1673-9078.2021.8.0623.","journal-title":"Modern Food Sci Technol"},{"issue":"3","key":"2572_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3969\/j.issn.1671-7856.2021.03.005","volume":"31","author":"Y Liang","year":"2021","unstructured":"Liang Y, Huang Q, Liang T, et al. Proliferation and apoptosis of dioscin in Bel-7402 and LO2 cells [J]. Chinese J Comparat Med. 2021;31(3):30\u20135. https:\/\/doi.org\/10.3969\/j.issn.1671-7856.2021.03.005.","journal-title":"Chinese J Comparat Med"},{"key":"2572_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.fct.2013.05.054","volume":"59","author":"Y Wei","year":"2013","unstructured":"Wei Y, Xu Y, Han X, et al. Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway[J]. Food Chem Toxicol. 2013;59:118\u201328. https:\/\/doi.org\/10.1016\/j.fct.2013.05.054.","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"2572_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.7150\/jca.89831","volume":"15","author":"R Wang","year":"2024","unstructured":"Wang R, Li X, Gan Y, et al. Dioscin inhibits non-small cell lung cancer cells and activates apoptosis by downregulation of Survivin[J]. J Cancer. 2024;15(5):1366\u201377. https:\/\/doi.org\/10.7150\/jca.89831.","journal-title":"J Cancer"},{"key":"2572_CR30","doi-asserted-by":"publisher","first-page":"115138","DOI":"10.1016\/j.jep.2022.115138","volume":"292","author":"P Xi","year":"2022","unstructured":"Xi P, Niu Y, Zhang Y, et al. The mechanism of dioscin preventing lung cancer based on network pharmacology and experimental validation [J]. J Ethnopharmacol. 2022;292:115138.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2572_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3969\/i.issn.1003-1634.2024.03.002","volume":"40","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhang Z, Gong L, et al. Effect of dioscin on proliferation and apoptosis of oral squamous cell carcinoma cells[J]. J Clin Stomatol. 2024;40(3):131\u20135. https:\/\/doi.org\/10.3969\/i.issn.1003-1634.2024.03.002.","journal-title":"J Clin Stomatol"},{"issue":"7","key":"2572_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.13862\/j.cn43-1446\/r.2024.07.005","volume":"30","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang Z, Li Y, et al. Dioscin enhances DNA damage to promote apoptosis in oral squamous cell [J]. Guiding J Tradit Chinese Med Pharma. 2024;30(7):20\u20134. https:\/\/doi.org\/10.13862\/j.cn43-1446\/r.2024.07.005.","journal-title":"Guiding J Tradit Chinese Med Pharma"},{"issue":"3","key":"2572_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.phymed.2016.01.012","volume":"23","author":"X Zhao","year":"2016","unstructured":"Zhao X, Xu L, Zheng L, et al. Potent effects of dioscin against gastric cancer in vitro and in vivo [J]. Phytomedicine. 2016;23(3):274\u201382. https:\/\/doi.org\/10.1016\/j.phymed.2016.01.012.","journal-title":"Phytomedicine"},{"key":"2572_CR34","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3389\/fphar.2020.01099","volume":"11","author":"S He","year":"2020","unstructured":"He S, Yang J, Hong S, et al. Dioscin promotes prostate cancer cell apoptosis and inhibits cell invasion by increasing SHP1 phosphorylation and suppressing the subsequent MAPK signaling pathway [J]. Front Pharmacol. 2020;11:1099. https:\/\/doi.org\/10.3389\/fphar.2020.01099.","journal-title":"Front Pharmacol"},{"issue":"10","key":"2572_CR35","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer [J]. Nat Rev Genet. 2009;10(10):704\u201314. https:\/\/doi.org\/10.1038\/nrg2634.","journal-title":"Nat Rev Genet"},{"key":"2572_CR36","doi-asserted-by":"publisher","DOI":"10.26994\/d.cnki.gdlyu.2016.000052","author":"L Si","year":"2022","unstructured":"Si L. Preliminary investigating the activities of dioscin againstlaryngeal and pancreatic cancers [D]. Dalian Med Univ. 2022. https:\/\/doi.org\/10.26994\/d.cnki.gdlyu.2016.000052.","journal-title":"Dalian Med Univ"},{"issue":"7","key":"2572_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bph.13718","volume":"174","author":"L Si","year":"2017","unstructured":"Si L, Xu L, Yin L, et al. Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway [J]. Br J Pharmacol. 2017;174(7):553\u201368. https:\/\/doi.org\/10.1111\/bph.13718.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2572_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer[J]. Mol Cancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"issue":"1","key":"2572_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.19367\/j.cnki.2096-8388.2024.01.013","volume":"49","author":"M Yang","year":"2024","unstructured":"Yang M, Ran H, Wang H, et al. Effect of dioscin on proliferation and apoptosis of hepatocarcinoma cell lineBel-7402 via Pl3K\/AKT pathway [J]. J Guizhou Med Univ. 2024;49(1):96\u2013100. https:\/\/doi.org\/10.19367\/j.cnki.2096-8388.2024.01.013.","journal-title":"J Guizhou Med Univ"},{"issue":"6","key":"2572_CR40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7150\/ijbs.18732","volume":"13","author":"X Song","year":"2017","unstructured":"Song X, Wang Z, Liang H, et al. Dioscin induces gallbladder cancer apoptosis by inhibiting ROS-mediated PI3K\/AKT signalling [J]. Int J Biol Sci. 2017;13(6):782\u201393. https:\/\/doi.org\/10.7150\/ijbs.18732.","journal-title":"Int J Biol Sci"},{"key":"2572_CR41","unstructured":"Guan J, Xun J, Wang B, et al. The effect and underlying mechanism of Dioscin on apoptosis of human colon cancer cells[J]. Journal of Tianjin Medical University, 2022, 28(5): 483\u2013490. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CJFQ&dbname=CJFDLAST2022& filename=TJYK202205005"},{"key":"2572_CR42","doi-asserted-by":"publisher","DOI":"10.27162\/d.cnki.gjlin.2024.003067","author":"P Cai","year":"2024","unstructured":"Cai P. Effect and mechanism of dioscin on biological behavior andchemotherapeutic sensitivity of breast cancer cells [D]. Jilin University. 2024. https:\/\/doi.org\/10.27162\/d.cnki.gjlin.2024.003067.","journal-title":"Jilin University"},{"key":"2572_CR43","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, et al. ROS and the DNA damage response in cancer [J]. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"issue":"3","key":"2572_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling [J]. Biochem J. 2010;429(3):403\u201317. https:\/\/doi.org\/10.1042\/BJ20100323.","journal-title":"Biochem J"},{"issue":"3","key":"2572_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/CAD.0000000000000590","volume":"29","author":"S Li","year":"2018","unstructured":"Li S, Cheng B, Hou L, et al. Dioscin inhibits colon cancer cells\u2019 growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathways [J]. Anticancer Drugs. 2018;29(3):234\u201342. https:\/\/doi.org\/10.1097\/CAD.0000000000000590.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"2572_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ddr.22009","volume":"84","author":"GZ Zheng","year":"2023","unstructured":"Zheng GZ, Zhang QH, Chang B, et al. Dioscin induces osteosarcoma cell apoptosis by upregulating ROS-mediated P38 MAPK signalling [J]. Drug Dev Res. 2023;84(1):25\u201335. https:\/\/doi.org\/10.1002\/ddr.22009.","journal-title":"Drug Dev Res"},{"key":"2572_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.04.018","author":"Y W, QY H, JF C.","year":"2024","unstructured":"Y W, QY H, JF C. Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line [J]. European J Pharma. 2024. https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.018.","journal-title":"European J Pharma"},{"key":"2572_CR48","doi-asserted-by":"publisher","DOI":"10.26973\/d.cnki.gbjzu.2023.000732","author":"Q Sun","year":"2024","unstructured":"Sun Q. Study on the inhibitory effect and potential mechanism of natural product diosgenin on hepatocellular carcinoma stem cells [D]. Beijing Univ Chinese Med. 2024. https:\/\/doi.org\/10.26973\/d.cnki.gbjzu.2023.000732.","journal-title":"Beijing Univ Chinese Med"},{"key":"2572_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116146","volume":"171","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang T, Liu W, et al. Anticancer effects of solasonine: evidence and possible mechanisms [J]. Biomed Pharmacother. 2024;171: 116146. https:\/\/doi.org\/10.1016\/j.biopha.2024.116146.","journal-title":"Biomed Pharmacother"},{"key":"2572_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2016.02.009","volume":"774","author":"L Si","year":"2016","unstructured":"Si L, Zheng L, Xu L, et al. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion [J]. Eur J Pharmacol. 2016;774:105\u201317. https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.009.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2572_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ol.2020.12321","volume":"21","author":"P Wang","year":"2021","unstructured":"Wang P, Wang C, Liu C. Antitumor effects of dioscin in A431 cells via adjusting ATM\/p53-mediated cell apoptosis, DNA damage and migration [J]. Oncol Lett. 2021;21(1):59. https:\/\/doi.org\/10.3892\/ol.2020.12321.","journal-title":"Oncol Lett"},{"key":"2572_CR52","doi-asserted-by":"publisher","DOI":"10.27787\/d.cnki.ghrbs.2023.000419","author":"L Yi","year":"2023","unstructured":"Yi L. Study on extraction, separation and antitumoractivity of saponins of rhizoma polygonati and dioscin [D]. Harbin University Commerce. 2023. https:\/\/doi.org\/10.27787\/d.cnki.ghrbs.2023.000419.","journal-title":"Harbin University Commerce"},{"issue":"12","key":"2572_CR53","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.phymed.2016.07.003","volume":"23","author":"G Zhang","year":"2016","unstructured":"Zhang G, Zeng X, Zhang R, et al. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3 [J]. Phytomedicine. 2016;23(12):1329\u201336. https:\/\/doi.org\/10.1016\/j.phymed.2016.07.003.","journal-title":"Phytomedicine"},{"key":"2572_CR54","doi-asserted-by":"publisher","DOI":"10.27202\/d.cnki.gkmyc.2020.000837","author":"S Wang","year":"2021","unstructured":"Wang S. Dioscin regulates endoplasmic reticulum stress-inducedapoptosis of colon cancer cells and its mechanism [D]. Kunming Medical University. 2021. https:\/\/doi.org\/10.27202\/d.cnki.gkmyc.2020.000837.","journal-title":"Kunming Medical University"},{"issue":"3","key":"2572_CR55","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/jcp.29197","volume":"235","author":"Q Ding","year":"2020","unstructured":"Ding Q, Zhang W, Cheng C, et al. Dioscin inhibits the growth of human osteosarcoma by inducing G2\/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo[J]. J Cell Physiol. 2020;235(3):2911\u201324. https:\/\/doi.org\/10.1002\/jcp.29197.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2572_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12032-022-01871-0","volume":"40","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Aisha S, et al. Redox balance and autophagy regulation in cancer progression and their therapeutic perspective [J]. Med Oncol (Northwood, London, England). 2022;40(1):12. https:\/\/doi.org\/10.1007\/s12032-022-01871-0.","journal-title":"Med Oncol (Northwood, London, England)"},{"key":"2572_CR57","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1038\/srep28403","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Huo X, Wang L, et al. Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7\/ADR cells through autophagy induction: more than just down-regulation of MDR1[J]. Sci Rep. 2016;6:28403. https:\/\/doi.org\/10.1038\/srep28403.","journal-title":"Sci Rep"},{"issue":"11","key":"2572_CR58","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00204-013-1047-z","volume":"87","author":"MJ Hsieh","year":"2013","unstructured":"Hsieh MJ, Tsai TL, Hsieh YS, et al. Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K\/Akt and ERK and JNK signaling pathways in human lung cancer cell lines[J]. Arch Toxicol. 2013;87(11):1927\u201337. https:\/\/doi.org\/10.1007\/s00204-013-1047-z.","journal-title":"Arch Toxicol"},{"key":"2572_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00978-7","author":"T Ma","year":"2023","unstructured":"Ma T, Ge X, Zhu J, et al. Dioscin impedes proliferation, metastasis and enhances autophagy of gastric cancer cells via regulating the USP8\/tgm2 pathway [J]. Mol Biotechnol. 2023. https:\/\/doi.org\/10.1007\/s12033-023-00978-7.","journal-title":"Mol Biotechnol"},{"issue":"7","key":"2572_CR60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/bph.14594","volume":"176","author":"Z Mao","year":"2019","unstructured":"Mao Z, Han X, Chen D, et al. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage [J]. Br J Pharmacol. 2019;176(7):919\u201337. https:\/\/doi.org\/10.1111\/bph.14594.","journal-title":"Br J Pharmacol"},{"key":"2572_CR61","unstructured":"Wu L, Ge Y. Dioscin affects the proliferation and invasionof osteosarcoma cells by regulatingAMPK\/mTOR autophagy signaling pathway[J]. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 2024, 34(4): 304\u2013309, 316.https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CJFQ&dbname=CJFDLAST2024&filename=ZJZH202404004"},{"issue":"8","key":"2572_CR62","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/life11080749","volume":"11","author":"S Okubo","year":"2021","unstructured":"Okubo S, Ohta T, Shoyama Y, et al. Steroidal saponins isolated from the rhizome of dioscorea tokoro inhibit cell growth and autophagy in hepatocellular carcinoma cells [J]. Life (Basel, Switzerland). 2021;11(8):749. https:\/\/doi.org\/10.3390\/life11080749.","journal-title":"Life (Basel, Switzerland)"},{"key":"2572_CR63","doi-asserted-by":"publisher","first-page":"108522","DOI":"10.1016\/j.pharmthera.2023.108522","volume":"250","author":"SU Khan","year":"2023","unstructured":"Khan SU, Fatima K, Malik F, et al. Cancer metastasis: molecular mechanisms and clinical perspectives [J]. Pharmacol Ther. 2023;250:108522. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108522.","journal-title":"Pharmacol Ther"},{"issue":"15","key":"2572_CR64","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.bmcl.2017.06.014","volume":"27","author":"WC Lim","year":"2017","unstructured":"Lim WC, Kim H, Kim YJ, et al. Dioscin suppresses TGF-\u03b21-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion [J]. Bioorg Med Chem Lett. 2017;27(15):3342\u20138. https:\/\/doi.org\/10.1016\/j.bmcl.2017.06.014.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"2572_CR65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.11844\/cicb.2018.05.0313","volume":"40","author":"R Fang","year":"2018","unstructured":"Fang R, Zhao J, Sheng F, et al. Dioscin inhibits EMT and invasion of triple negative breast cancer cells viaActivation of p38MAPK\/FOXO3a signaling [J]. Chinese J Cell Biol. 2018;40(5):640\u20137. https:\/\/doi.org\/10.11844\/cicb.2018.05.0313.","journal-title":"Chinese J Cell Biol"},{"key":"2572_CR66","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.2147\/DDDT.S249651","volume":"14","author":"W Mao","year":"2020","unstructured":"Mao W, Yin H, Chen W, et al. Network pharmacology and experimental evidence reveal dioscin suppresses proliferation, invasion, and EMT via AKT\/GSK3b\/mTOR signaling in lung adenocarcinoma [J]. Drug Des Dev Ther. 2020;14:2135\u201347. https:\/\/doi.org\/10.2147\/DDDT.S249651.","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"2572_CR67","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/ijc.30872","volume":"141","author":"Y Kou","year":"2017","unstructured":"Kou Y, Ji L, Wang H, et al. Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization [J]. Int J Cancer. 2017;141(8):1690\u2013703. https:\/\/doi.org\/10.1002\/ijc.30872.","journal-title":"Int J Cancer"},{"issue":"23","key":"2572_CR68","doi-asserted-by":"publisher","first-page":"210","DOI":"10.13422\/j.cnki.syfjx.20212321","volume":"27","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang X, Mu Y, et al. Anti-tumor effect and mechanisms of calycosin: a review [J]. Chin J Exp Tradit Med Formulae. 2021;27(23):210\u20137. https:\/\/doi.org\/10.13422\/j.cnki.syfjx.20212321.","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"2572_CR69","doi-asserted-by":"publisher","DOI":"10.27202\/d.cnki.gkmyc.2022.000833","author":"J Tan","year":"2023","unstructured":"Tan J. Inhibitory effect and mechanism of dioscin on colon cancer [D]. Kunming Med Univ. 2023. https:\/\/doi.org\/10.27202\/d.cnki.gkmyc.2022.000833.","journal-title":"Kunming Med Univ"},{"key":"2572_CR70","doi-asserted-by":"publisher","DOI":"10.27441\/d.cnki.gyzdu.2021.002045","author":"H Gu","year":"2022","unstructured":"Gu H. Effects and mechanism of Dio on invasion and metastasisof gastric cancer [D]. Yangzhou Univ. 2022. https:\/\/doi.org\/10.27441\/d.cnki.gyzdu.2021.002045.","journal-title":"Yangzhou Univ"},{"issue":"7","key":"2572_CR71","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00228-012-1232-7","volume":"68","author":"S Taugourdeau-Raymond","year":"2012","unstructured":"Taugourdeau-Raymond S, Rouby F, Default A, et al. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database [J]. Eur J Clin Pharmacol. 2012;68(7):1103\u20137. https:\/\/doi.org\/10.1007\/s00228-012-1232-7.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2572_CR72","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.taap.2014.07.026","volume":"281","author":"Q Tong","year":"2014","unstructured":"Tong Q, Qing Y, Wu Y, et al. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT\/MAPK signaling pathways[J]. Toxicol Appl Pharmacol. 2014;281(2):166\u201373. https:\/\/doi.org\/10.1016\/j.taap.2014.07.026.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2572_CR73","doi-asserted-by":"publisher","unstructured":"Li L, Dai X, Zhang J, et al. Effects of dioscin on metastatic activity and Pl3K\/AKT pathway of ovarian cancer cells in vitro[J]. Progress Anatom Sci: 1\u20135. https:\/\/doi.org\/10.16695\/j.cnki.1006-2947.2023.05.015","DOI":"10.16695\/j.cnki.1006-2947.2023.05.015"},{"issue":"6","key":"2572_CR74","doi-asserted-by":"publisher","first-page":"9537","DOI":"10.3892\/ol.2018.8454","volume":"15","author":"X Guo","year":"2018","unstructured":"Guo X, Ding X. Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K\/AKT\/MAPK signaling pathways [J]. Oncol Lett. 2018;15(6):9537\u201342. https:\/\/doi.org\/10.3892\/ol.2018.8454.","journal-title":"Oncol Lett"},{"issue":"18","key":"2572_CR75","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.19540\/j.cnki.cjcmm.20230614.601","volume":"48","author":"X Liang","year":"2023","unstructured":"Liang X, Li Y, Bai H, et al. Recent advances in nanocarrier-based drug delivery systems in treatmentof rheumatoid arthritis [J]. China J Chin Mater Med. 2023;48(18):4874\u201383. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20230614.601.","journal-title":"China J Chin Mater Med"},{"key":"2572_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03639045.2020.1763397","volume":"46","author":"YX Min","year":"2020","unstructured":"Min YX, Ju NF, Kong L, et al. GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial\u2013mesenchymal transition [J]. Drug Dev Ind Pharma. 2020;46:1\u201315. https:\/\/doi.org\/10.1080\/03639045.2020.1763397.","journal-title":"Drug Dev Ind Pharma"},{"key":"2572_CR77","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.2147\/IJN.S194304","volume":"14","author":"Y Wang","year":"2019","unstructured":"Wang Y, Fu M, Liu J, et al. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer [J]. Int J Nanomed. 2019;14:4071\u201390. https:\/\/doi.org\/10.2147\/IJN.S194304.","journal-title":"Int J Nanomed"},{"key":"2572_CR78","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.2147\/IJN.S258906","volume":"15","author":"L Kong","year":"2020","unstructured":"Kong L, Zhang SM, Chu JH, et al. Tumor microenvironmental responsive liposomes simultaneously encapsulating biological and chemotherapeutic drugs for enhancing antitumor efficacy of NSCLC [J]. Int J Nanomed. 2020;15:6451\u201368. https:\/\/doi.org\/10.2147\/IJN.S258906.","journal-title":"Int J Nanomed"},{"key":"2572_CR79","doi-asserted-by":"publisher","first-page":"112448","DOI":"10.1016\/j.colsurfb.2022.112448","volume":"214","author":"D Wang","year":"2022","unstructured":"Wang D, Sha L, Xu C, et al. Natural saponin and cholesterol assembled nanostructures as the promising delivery method for saponin [J]. Coll Surfaces B. 2022;214:112448. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112448.","journal-title":"Coll Surfaces B"},{"issue":"7","key":"2572_CR80","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/03639045.2017.1304956","volume":"43","author":"J Zhao","year":"2017","unstructured":"Zhao J, Xu Y, Wang C, et al. Soluplus\/TPGS mixed micelles for dioscin delivery in cancer therapy [J]. Drug Dev Ind Pharm. 2017;43(7):1197\u2013204. https:\/\/doi.org\/10.1080\/03639045.2017.1304956.","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"2572_CR81","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3870\/j.issn.1004-0781.2017.06.005","volume":"36","author":"X Bai","year":"2017","unstructured":"Bai X, Liu S, Wang J, et al. In vivo intestinal absorption characteristics of dioscin from dioscorea nipponica makino extract in rat [J]. Herald Med. 2017;36(6):610\u20133. https:\/\/doi.org\/10.3870\/j.issn.1004-0781.2017.06.005.","journal-title":"Herald Med"},{"key":"2572_CR82","unstructured":"Li K. Pharmacokinetic studies of dioscin and ginsenoside Rg3 in animals[D]. Shenyang Pharmaceutical University, 2007. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CDFD&dbname=CDFD9908&filename=2006178274.nh"},{"issue":"13","key":"2572_CR83","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3969\/j.issn.1007-1865.2024.013.040","volume":"51","author":"X Hou","year":"2024","unstructured":"Hou X, Zhu L, Sun S, et al. experimental teaching design of pharmaceutics integrated with scientificresearch: preparation and characterization of dioscin plga nanoparticles [J]. Guangdong Chem Ind. 2024;51(13):148\u201350. https:\/\/doi.org\/10.3969\/j.issn.1007-1865.2024.013.040.","journal-title":"Guangdong Chem Ind"},{"issue":"10","key":"2572_CR84","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/0008-5472.CAN-06-1648","volume":"67","author":"LE Van Vlerken","year":"2007","unstructured":"Van Vlerken LE, Duan Z, Seiden MV, et al. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer [J]. Can Res. 2007;67(10):4843\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1648.","journal-title":"Can Res"},{"issue":"5","key":"2572_CR85","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","volume":"39","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Malik F. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis [J]. Clin Exp Metas. 2022;39(5):715\u201326. https:\/\/doi.org\/10.1007\/s10585-022-10172-9.","journal-title":"Clin Exp Metas"},{"issue":"1","key":"2572_CR86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, Fatima K, Aisha S, et al. Unveiling the mechanisms and challenges of cancer drug resistance [J]. Cell Commun Signal. 2024;22(1):109. https:\/\/doi.org\/10.1186\/s12964-023-01302-1.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"2572_CR87","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2010.12.018","volume":"654","author":"BT Sun","year":"2011","unstructured":"Sun BT, Zheng LH, Bao YL, et al. Reversal effect of dioscin on multidrug resistance in human hepatoma HepG2\/adriamycin cells[J]. Eur J Pharmacol. 2011;654(2):129\u201334. https:\/\/doi.org\/10.1016\/j.ejphar.2010.12.018.","journal-title":"Eur J Pharmacol"},{"issue":"29","key":"2572_CR88","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.12114\/j.issn.1007-9572.2019.00.270","volume":"22","author":"H Shen","year":"2019","unstructured":"Shen H, Ding X. Effects of dioscin on the growth of tamoxifen-resistant breast cancer cells [J]. Chinese General Practice. 2019;22(29):3570\u20135. https:\/\/doi.org\/10.12114\/j.issn.1007-9572.2019.00.270.","journal-title":"Chinese General Practice"},{"issue":"16","key":"2572_CR89","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.13286\/j.1001-5213.2024.16.04","volume":"44","author":"X Ding","year":"2024","unstructured":"Ding X, Zhang H, Xie M, et al. Mechanism of dioscin in reversingdoxorubicin resistance of breast cancer basedupon cell assays and network pharmacology [J]. Chinese J Hospital Pharma. 2024;44(16):1868\u201374. https:\/\/doi.org\/10.13286\/j.1001-5213.2024.16.04.","journal-title":"Chinese J Hospital Pharma"},{"issue":"1","key":"2572_CR90","first-page":"34","volume":"23","author":"Z Song","year":"2020","unstructured":"Song Z, Zhang Q. Effect of diosgenin on drug resistance of human hepatocellular carcinoma HepG2\/ADM cells by down-regulating ABCC1 expression [J]. China Pharmacist. 2020;23(1):34\u20139.","journal-title":"China Pharmacist"},{"key":"2572_CR91","unstructured":"Hao M, Wang C, Zhang X, et al. Research progress on the mechanism ofmonomeric saponins in Chinese herbalmedicine in anti-tumor immunity[J]. Chinese Journal of Immunology, 2024: 1\u201325. Research progress on the mechanism ofmonomeric saponins in Chinese herbalmedicine in anti-tumor immunity https:\/\/link.cnki.net\/urlid\/22.1126.R.20240329.0940.002"},{"key":"2572_CR92","doi-asserted-by":"publisher","DOI":"10.27044\/d.cnki.ggzzu.2022.000020","author":"W Zhang","year":"2022","unstructured":"Zhang W. Dioscin potentiated the antitumor immunity of suicide genetherapy on melanoma by GJIC - mediated antigencross-presentation [D]. Guangzhou Univ Tradit Chinese Med. 2022. https:\/\/doi.org\/10.27044\/d.cnki.ggzzu.2022.000020.","journal-title":"Guangzhou Univ Tradit Chinese Med"},{"key":"2572_CR93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2022.10.104","volume":"638","author":"R Li","year":"2023","unstructured":"Li R, Qin J, Wang Z, et al. Dioscin reduced chemoresistance for colon cancer and analysis of sensitizing targets[J]. Biochem Biophys Res Commun. 2023;638:94\u2013102. https:\/\/doi.org\/10.1016\/j.bbrc.2022.10.104.","journal-title":"Biochem Biophys Res Commun"},{"key":"2572_CR94","unstructured":"Li B. The Enhancing Effect of Dioscin on HSV-tk\/GCV Suicide Gene Therapy System by Gap Junction[D]. Guangzhou University of Traditional Chinese Medicine, 2015. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CDFD&dbname=CDFDLAST2015&filename=1014359067.nh"},{"issue":"2","key":"2572_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3872\/j.issn.1007-385X.2016.02.001","volume":"23","author":"Z Guo","year":"2016","unstructured":"Guo Z, Cao X. The current situation and prospect ofimmunocyte-therapy for tumor [J]. Chinese J Cancer Biotherapy. 2016;23(2):149\u201360. https:\/\/doi.org\/10.3872\/j.issn.1007-385X.2016.02.001.","journal-title":"Chinese J Cancer Biotherapy"},{"key":"2572_CR96","doi-asserted-by":"publisher","first-page":"112973","DOI":"10.1016\/j.biopha.2022.112973","volume":"150","author":"W Zhang","year":"2022","unstructured":"Zhang W, Lin L, Zhang Y, et al. Dioscin potentiates the antitumor effect of suicide gene therapy in melanoma by gap junction intercellular communication-mediated antigen cross-presentation [J]. Biomed Pharma. 2022;150:112973. https:\/\/doi.org\/10.1016\/j.biopha.2022.112973.","journal-title":"Biomed Pharma"},{"issue":"14","key":"2572_CR97","first-page":"2748","volume":"40","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Wang Y, Ma Z, et al. Preliminary study on hepatotoxicity inducedby dioscin and its possible mechanism [J]. China J Chin Materia Med. 2015;40(14):2748\u201352.","journal-title":"China J Chin Materia Med"},{"key":"2572_CR98","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.biopha.2016.08.017","volume":"83","author":"F Yang","year":"2016","unstructured":"Yang F, Liang Y, Xu L, et al. Exploration in the cascade working mechanisms of liver injury induced by total saponins extracted from rhizoma dioscorea bulbifera [J]. Biomed Pharma. 2016;83:1048\u201356. https:\/\/doi.org\/10.1016\/j.biopha.2016.08.017.","journal-title":"Biomed Pharma"},{"issue":"2","key":"2572_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.13412\/j.cnki.zyyl.2013.02.007","volume":"29","author":"Q Zhou","year":"2013","unstructured":"Zhou Q, Yao G, Jin R. Preliminary study on hepatotoxicity inducedby dioscin [J]. Pharmacol Clin Chinese Materi Med. 2013;29(2):29\u201332. https:\/\/doi.org\/10.13412\/j.cnki.zyyl.2013.02.007.","journal-title":"Pharmacol Clin Chinese Materi Med"},{"key":"2572_CR100","unstructured":"Jiang P, Jiang Y. Diao Xuexikang clinical adverse reaction prevention[J]. Lishizhen Medicine and Materia Medica Research, 2006(5): 828\u2013829. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CJFQ&dbname=CJFD2006&filename=SZGY200605114"},{"key":"2572_CR101","unstructured":"Lei Z. Analysis of adverse reactions of Diao Xuexikang capsule[J]. Chinese Traditional Patent Medicine, 2011, 33(6): 1037\u20131039. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbcode=CJFQ&dbname=CJFD2011&filename=ZCYA201106038"},{"key":"2572_CR102","unstructured":"Zhou Y, Lu Y, Che W. Diao Xuexikang caused liver damage in 2 cases[J]. Chinese Pharmaceutical Affairs, 1999(2): 60\u201361. https:\/\/kns.cnki.net\/KCMS\/detail\/detail. aspx?dbcode=CJFQ&dbname=CJFD9899&filename=ZGYS902.040"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02572-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:17:25Z","timestamp":1741270645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02572-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":102,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2572"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02572-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"63"}}